Hans H. Hirsch
Experienced in Interstitial Nephritis

Hans H. Hirsch

Basel, BS, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Interstitial Nephritis
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Hans Hirsch practices in Basel, Switzerland. Mr. Hirsch is rated as an Experienced expert by MediFind in the treatment of Interstitial Nephritis. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Sepsis, Kidney Transplant, and Bone Marrow Transplant.

His clinical research consists of co-authoring 292 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Interstitial Nephritis.

Gender
Male

Locations

Basel, BS, Switzerland
Other Locations
Lausanne, VD, Switzerland
Bruderholz, BS, Switzerland
Zurich, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens
Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Diagnostic test
A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City
A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Other
Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
Enrollment Status: Completed
Publish Date: April 28, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

291 Total Publications

Corrigendum to 'American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients' [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016].
Corrigendum to 'American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients' [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016].
Journal: Transplantation and cellular therapy
Published: October 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hirsch's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile